Normal view MARC view ISBD view

Correction of a Depth-Dependent Lateral Distortion in 3D Super-Resolution Imaging. [electronic resource]

By:

Carlini, Lina

Contributor(s):

Producer: 20160620Description: e0142949 p. digitalISSN:

1932-6203

Subject(s):

Online resources:

Available from publisher's website

In: PloS one vol. 10

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

3941 Acute phosphorus poisoning: a case with severe granulocytopenia and hypoprothrombinemia.
by EHRENTHEIL, O F
3942 The response of hypoprothrombinemia in cirrhosis to vitamin K1 and K3.
by WEINER, M
3943 Oral IIa inhibitors.
by Lee, Catherine J
3944 The concentration of the labile factor of the prothrombin complex in human, dog, and rabbit blood; its significance in the determination of prothrombin activity.
by QUICK, A J
3945 Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity.
by Nielsen, Vance G
3946 Coagulation abnormalities in patients who have liver disease.
by Trotter, James F
3947 Hydroxyethyl starch does not decrease prothrombin to thrombin conversion.
by Nielsen, V G
3948 And the question is...Is the patient bleeding or clotting? A guide to appropriate testing and evaluation.
by Miller-Canfield, Patricia A
3949 [Prothrombin index prolongation due to N-acetylcysteine during the treatment of Amanita phalloides poisoning].
by Fernández de Larrea, Carlos
3950 A study of prothrombin activity and platelet counts in 61 patients with meningococcus meningitis.
by RHOADS, P S
3951 [Action of vitreous body in the blood coagulation].
by Regnault, F
3952 Validity of the INR system for patients with liver impairment.
by Denson, K W
3953 Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
by Herring, S W
3954 Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K.
by Cornelissen, E A
3955 Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.
by Koestenberger, Martin
3956 Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.
by Borowiecka, Marta
3957 Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy.
by Gazzard, B G
3958 [Hemocoagulation and fibrinolytic properties of the gastric wall involved in ulcerous and cancerous processes].
by Kal'chenko, I I
3959 Mechanism of warfarin resistance. Warfarin and the metabolism of vitamin K 1 .
by Bell, R G
3960 Coagulation changes in isolated perfused lungs.
by Deysine, M